SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells

Area of Science:

• Molecular Biology
• Cancer Research
• Gene Regulation

Background:

• Apoptosis is crucial for cancer cell regulation.
• SOX7 gene expression is often reduced in various cancers, particularly lung and breast types.
• Low SOX7 levels correlate with advanced cancer stages and poorer patient survival.

Purpose of the Study:

• To investigate the role of SOX7 in cancer cell apoptosis and drug resistance.
• To elucidate the molecular mechanisms by which SOX7 regulates apoptosis.
• To identify potential therapeutic strategies targeting SOX7 expression.

Main Methods:

• Analysis of SOX7 expression in cancer patient data.
• In vitro studies on cancer cells with SOX7 loss or restoration.
• Investigation of signaling pathways involving SOX7, P38, MAPK/ERK, and BIM.
• Treatment with proteasome inhibitors and HDAC inhibitors.

Main Results:

• Loss of SOX7 enhances cancer cell survival, colony formation, and chemoresistance.
• SOX7 induces apoptosis by upregulating P38 and apoptotic signaling pathways.
• SOX7 prevents proteasome-mediated degradation of the pro-apoptotic protein BIM.
• Panobinostat, an FDA-approved HDAC inhibitor, restores SOX7 expression in silenced cells.

Conclusions:

• SOX7 plays a critical role in regulating cancer cell apoptosis and drug sensitivity.
• SOX7 influences apoptosis via the MAPK/ERK-BIM signaling pathway.
• Targeting SOX7 expression or its downstream pathways presents a potential therapeutic avenue for cancer treatment.